Annual EBITDA:
$147.03M+$117.06M(+390.68%)Summary
- As of today, ADMA annual EBITDA is $147.03 million, with the most recent change of +$117.06 million (+390.68%) on December 31, 2024.
- During the last 3 years, ADMA annual EBITDA has risen by +$200.15 million (+376.80%).
- ADMA annual EBITDA is now at all-time high.
Performance
ADMA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$43.99M+$6.59M(+17.64%)Summary
- As of today, ADMA quarterly EBITDA is $43.99 million, with the most recent change of +$6.59 million (+17.64%) on June 30, 2025.
- Over the past year, ADMA quarterly EBITDA has increased by +$2.31 million (+5.54%).
- ADMA quarterly EBITDA is now at all-time high.
Performance
ADMA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$163.11M+$2.31M(+1.44%)Summary
- As of today, ADMA TTM EBITDA is $163.11 million, with the most recent change of +$2.31 million (+1.44%) on June 30, 2025.
- Over the past year, ADMA TTM EBITDA has increased by +$95.41 million (+140.93%).
- ADMA TTM EBITDA is now at all-time high.
Performance
ADMA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ADMA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +390.7% | +5.5% | +140.9% |
| 3Y3 Years | +376.8% | +689.1% | +411.8% |
| 5Y5 Years | +485.2% | +371.1% | +415.1% |
ADMA EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +376.8% | at high | +571.9% | at high | +448.8% |
| 5Y | 5-Year | at high | +341.1% | at high | +319.6% | at high | +372.7% |
| All-Time | All-Time | at high | +341.1% | at high | +319.6% | at high | +372.7% |
ADMA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $43.99M(+17.6%) | $163.11M(+1.4%) |
| Mar 2025 | - | $37.39M(-5.4%) | $160.80M(+8.9%) |
| Dec 2024 | $147.03M(+390.7%) | $39.54M(-6.3%) | $147.69M(+49.4%) |
| Sep 2024 | - | $42.19M(+1.2%) | $98.83M(+46.0%) |
| Jun 2024 | - | $41.68M(+71.6%) | $67.70M(+141.4%) |
| Mar 2024 | - | $24.28M(+360.5%) | $28.04M(+447.8%) |
| Dec 2023 | $29.96M(+192.3%) | -$9.32M(-184.3%) | $5.12M(-48.2%) |
| Sep 2023 | - | $11.05M(+445.7%) | $9.88M(+214.5%) |
| Jun 2023 | - | $2.03M(+49.1%) | -$8.63M(+52.4%) |
| Mar 2023 | - | $1.36M(+129.8%) | -$18.12M(+54.1%) |
| Dec 2022 | -$32.46M(+38.9%) | -$4.56M(+38.9%) | -$39.51M(+15.5%) |
| Sep 2022 | - | -$7.46M(+0.1%) | -$46.77M(+10.6%) |
| Jun 2022 | - | -$7.47M(+62.7%) | -$52.30M(+11.6%) |
| Mar 2022 | - | -$20.03M(-69.5%) | -$59.17M(-11.4%) |
| Dec 2021 | -$53.12M(+12.9%) | -$11.82M(+9.1%) | -$53.09M(+5.8%) |
| Sep 2021 | - | -$12.99M(+9.4%) | -$56.35M(-0.4%) |
| Jun 2021 | - | -$14.33M(-2.7%) | -$56.14M(+3.3%) |
| Mar 2021 | - | -$13.95M(+7.4%) | -$58.04M(+3.0%) |
| Dec 2020 | -$60.97M(-59.8%) | -$15.07M(-17.8%) | -$59.82M(-15.6%) |
| Sep 2020 | - | -$12.79M(+21.2%) | -$51.76M(-10.3%) |
| Jun 2020 | - | -$16.23M(-3.1%) | -$46.94M(-14.4%) |
| Mar 2020 | - | -$15.74M(-124.8%) | -$41.04M(-13.9%) |
| Dec 2019 | -$38.17M(+27.9%) | -$7.00M(+12.2%) | -$36.03M(+19.4%) |
| Sep 2019 | - | -$7.97M(+22.9%) | -$44.70M(+9.9%) |
| Jun 2019 | - | -$10.33M(+3.6%) | -$49.62M(+4.3%) |
| Mar 2019 | - | -$10.72M(+31.6%) | -$51.83M(+8.7%) |
| Dec 2018 | -$52.94M(-67.7%) | -$15.68M(-21.7%) | -$56.77M(-10.5%) |
| Sep 2018 | - | -$12.89M(-2.7%) | -$51.38M(+1.3%) |
| Jun 2018 | - | -$12.54M(+20.0%) | -$52.08M(-9.3%) |
| Mar 2018 | - | -$15.67M(-52.4%) | -$47.65M(-26.1%) |
| Dec 2017 | -$31.57M | -$10.28M(+24.3%) | -$37.78M(-20.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$13.58M(-67.4%) | -$31.31M(-46.7%) |
| Jun 2017 | - | -$8.12M(-39.9%) | -$21.34M(-14.8%) |
| Mar 2017 | - | -$5.80M(-52.1%) | -$18.58M(-10.6%) |
| Dec 2016 | -$16.86M(-12.1%) | -$3.81M(-5.7%) | -$16.81M(+1.1%) |
| Sep 2016 | - | -$3.61M(+32.7%) | -$16.99M(+5.2%) |
| Jun 2016 | - | -$5.36M(-33.1%) | -$17.92M(-7.5%) |
| Mar 2016 | - | -$4.03M(-0.6%) | -$16.67M(-6.5%) |
| Dec 2015 | -$15.04M(+4.6%) | -$4.00M(+11.8%) | -$15.66M(-2.4%) |
| Sep 2015 | - | -$4.54M(-10.4%) | -$15.29M(-11.2%) |
| Jun 2015 | - | -$4.11M(-36.4%) | -$13.75M(-4.1%) |
| Mar 2015 | - | -$3.01M(+17.2%) | -$13.21M(+16.5%) |
| Dec 2014 | -$15.77M(-6.3%) | -$3.64M(-21.4%) | -$15.83M(+5.1%) |
| Sep 2014 | - | -$3.00M(+16.1%) | -$16.68M(-3.2%) |
| Jun 2014 | - | -$3.57M(+36.6%) | -$16.15M(+6.4%) |
| Mar 2014 | - | -$5.63M(-25.6%) | -$17.26M(-17.4%) |
| Dec 2013 | -$14.83M(-91.9%) | -$4.48M(-81.4%) | -$14.70M(-7.1%) |
| Sep 2013 | - | -$2.47M(+47.2%) | -$13.72M(+1.7%) |
| Jun 2013 | - | -$4.68M(-52.4%) | -$13.96M(-33.7%) |
| Mar 2013 | - | -$3.07M(+12.5%) | -$10.44M(-22.4%) |
| Dec 2012 | -$7.73M(-213.0%) | -$3.51M(-29.3%) | -$8.53M(-69.7%) |
| Sep 2012 | - | -$2.71M(-134.2%) | -$5.03M(-116.9%) |
| Jun 2012 | - | -$1.16M(+0.3%) | -$2.32M(-99.7%) |
| Mar 2012 | - | -$1.16M(>-9900.0%) | -$1.16M(-5104.9%) |
| Dec 2011 | -$2.47M(+53.2%) | - | - |
| Mar 2011 | - | -$4900.00(+5.8%) | -$22.30K(-0.5%) |
| Dec 2010 | -$5.28M(>-9900.0%) | -$5200.00(-13.0%) | -$22.20K(-4.2%) |
| Sep 2010 | - | -$4600.00(+39.5%) | -$21.30K(-27.5%) |
| Jun 2010 | - | -$7600.00(-58.3%) | -$16.70K(-83.5%) |
| Jun 2010 | -$20.50K | - | - |
| Mar 2010 | - | -$4800.00(-11.6%) | -$9100.00(-111.6%) |
| Dec 2009 | - | -$4300.00 | -$4300.00 |
FAQ
- What is ADMA Biologics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. annual EBITDA year-on-year change?
- What is ADMA Biologics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. quarterly EBITDA year-on-year change?
- What is ADMA Biologics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for ADMA Biologics, Inc.?
- What is ADMA Biologics, Inc. TTM EBITDA year-on-year change?
What is ADMA Biologics, Inc. annual EBITDA?
The current annual EBITDA of ADMA is $147.03M
What is the all-time high annual EBITDA for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high annual EBITDA is $147.03M
What is ADMA Biologics, Inc. annual EBITDA year-on-year change?
Over the past year, ADMA annual EBITDA has changed by +$117.06M (+390.68%)
What is ADMA Biologics, Inc. quarterly EBITDA?
The current quarterly EBITDA of ADMA is $43.99M
What is the all-time high quarterly EBITDA for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high quarterly EBITDA is $43.99M
What is ADMA Biologics, Inc. quarterly EBITDA year-on-year change?
Over the past year, ADMA quarterly EBITDA has changed by +$2.31M (+5.54%)
What is ADMA Biologics, Inc. TTM EBITDA?
The current TTM EBITDA of ADMA is $163.11M
What is the all-time high TTM EBITDA for ADMA Biologics, Inc.?
ADMA Biologics, Inc. all-time high TTM EBITDA is $163.11M
What is ADMA Biologics, Inc. TTM EBITDA year-on-year change?
Over the past year, ADMA TTM EBITDA has changed by +$95.41M (+140.93%)